Small Molecule Targeted Therapy Global Market Report 2026
상품코드:1957806
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
저분자 표적치료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 772억 9,000만 달러에서 2026년에는 846억 6,000만 달러에 이르고, CAGR 9.5%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 분자생물학 연구의 발전, 만성질환의 유병률 증가, 제약사의 R&D 파이프라인 확대, 표적치료제에 대한 규제당국의 승인, 약물 스크리닝 기술의 향상 등을 꼽을 수 있습니다.
저분자 표적치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,206억 4,000만 달러에 이르고, CAGR은 9.3%를 나타낼 전망입니다. 예측 기간 동안의 성장에는 개인 맞춤형 의료 접근법에 대한 수요 증가, 신약 개발에 있어 유전체학 통합의 발전, 종양학 이외의 영역으로의 표적치료제 확대, 안전성 최적화 약물 설계에 대한 관심 증가, 정밀치료에 대한 투자 증가 등이 주요 요인으로 작용할 것으로 예측됩니다. 예측 기간의 주요 동향으로는 표적 특이적 약물 개발 확대, 경로 조절 요법 사용 증가, 경구용 저분자 치료제의 채택 확대, 질병 특이적 분자 표적에 대한 관심 증가, 저분자 병용요법 확대 등을 꼽을 수 있습니다.
맞춤형 의료에 대한 관심이 높아지면서 향후 몇 년간 저분자 표적치료제 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 요인, 환경적 요인, 생활습관에 따라 예방, 진단, 치료를 맞춤화하는 헬스케어 접근법입니다. 개인 맞춤형 의료의 부상은 유전체학의 발전에 의해 촉진되고 있습니다. 유전체학은 개인의 유전적 변이에 대한 깊은 이해를 가져와 치료의 시행착오를 최소화하면서 환자 결과를 개선하고, 보다 정밀하고 표적화된 치료를 가능하게 합니다. 저분자 표적치료제는 환자의 고유한 분자-유전적 질환 프로파일을 특이적으로 표적화하여 치료 효과를 높이고 부작용을 줄여 개인 맞춤형 의료를 지원합니다. 예를 들어, 2024년 2월 미국 비영리단체인 '맞춤의료연합'은 FDA가 2023년 희귀질환 환자를 위한 16건의 새로운 맞춤치료제를 승인했다고 보고했다(2022년 6건). 2023년 새롭게 승인된 맞춤치료제에는 7종의 암 치료제, 3종의 기타 질환 및 증상 치료제가 포함되어 있습니다. 이러한 맞춤형 의료에 대한 관심이 높아지면서 저분자 표적치료제 시장의 성장을 견인하고 있습니다.
저분자 표적치료제 시장에서 활동하는 주요 기업들은 표적 전달을 강화하고, 환자의 복약 순응도를 높이며, 종양학 및 기타 만성질환의 특정 분자 경로에 대응하기 위해 경구용 저분자 약물과 같은 혁신적인 접근법을 개발하는 데 주력하고 있습니다. 경구용 저분자 약물은 경구 투여되는 저분자량의 약물을 말하며, 세포 내로 효율적으로 흡수되어 질병 관련 단백질이나 경로를 특이적으로 표적하도록 설계되어 있습니다. 예를 들어, 2025년 6월 미국 소재 바이오기업 Kura Oncology Inc.는 뉴클레오포수민1(NPM1) 돌연변이가 있는 재발성 또는 불응성 급성골수성백혈병(AML) 성인 환자를 위한 치료제인 지프토메닙의 신약승인신청(NDA)을 FDA로부터 승인받았습니다. NDA)에 대해 FDA의 승인을 받았습니다. 이 경구용 표적치료제는 NPM1 돌연변이가 있는 재발성 또는 불응성 AML 성인 환자를 대상으로 하며, 큰 미충족 수요를 충족시킬 수 있는 치료제입니다. 우수한 안전성 프로파일을 보였으며, 임상시험에서 우수한 완전관해율을 포함한 유망한 효능을 확인했습니다. 지프토메닙은 메닌과 KMT2A의 상호작용을 선택적으로 억제함으로써 백혈병 세포의 증식을 억제하여 치료가 어려운 AML 아형에 대한 새로운 치료 옵션을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Small molecule targeted therapy involves low-molecular-weight drugs that directly interact with disease-associated targets like enzymes, receptors, or signaling proteins. They precisely inhibit or regulate disease pathways, enabling targeted treatment while minimizing effects on healthy cells.
The main therapy types of small molecule targeted therapy include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy involves the use of chemical drugs to eliminate rapidly dividing cells in the body. The primary drug classes, such as monoclonal antibodies, small molecule inhibitors, and combination therapies, function through mechanisms including kinase inhibitors, proteasome inhibitors, aromatic hydrocarbon receptor (AHR) modulators, and cell cycle inhibitors. This therapy is used to treat conditions like cancer, autoimmune disorders, and infectious diseases and can be administered orally, intravenously, or subcutaneously.
Tariffs are influencing the small molecule targeted therapy market by increasing costs of imported APIs, formulation excipients, analytical instruments, and precision manufacturing equipment. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on international supply chains, while Asia-Pacific faces export-related cost pressures. These tariffs are raising development and production costs and affecting drug pricing dynamics. At the same time, they are promoting regional API production, strengthening domestic pharmaceutical manufacturing, and accelerating supply chain diversification strategies.
The small molecule targeted therapy market research report is one of a series of new reports from The Business Research Company that provides small molecule targeted therapy market statistics, including small molecule targeted therapy industry global market size, regional shares, competitors with a small molecule targeted therapy market share, detailed small molecule targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule targeted therapy industry. This small molecule targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The small molecule targeted therapy market size has grown strongly in recent years. It will grow from $77.29 billion in 2025 to $84.66 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to advances in molecular biology research, increasing prevalence of chronic diseases, expansion of pharmaceutical R&D pipelines, regulatory acceptance of targeted therapies, improved drug screening technologies.
The small molecule targeted therapy market size is expected to see strong growth in the next few years. It will grow to $120.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine approaches, rising integration of genomics in drug development, expansion of targeted therapies beyond oncology, growing focus on safety-optimized drug design, increasing investment in precision therapeutics. Major trends in the forecast period include increasing expansion of target-specific drug development, rising use of pathway-modulating therapies, growing adoption of oral small molecule treatments, enhanced focus on disease-specific molecular targets, expansion of combination small molecule regimens.
The increasing focus on personalized medicine is anticipated to drive the growth of the small molecule targeted therapy market in the coming years. Personalized medicine is a healthcare approach that customizes prevention, diagnosis, and treatment based on an individual's genetic, environmental, and lifestyle factors. The rise of personalized medicine is fueled by advancements in genomics, which provide a deeper understanding of individual genetic variations and enable more precise, targeted treatments that enhance patient outcomes and minimize trial-and-error in therapies. Small molecule targeted therapy supports personalized medicine by specifically targeting a patient's unique molecular or genetic disease profile, enhancing treatment effectiveness and reducing side effects. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. The newly approved personalized treatments in 2023 also include seven cancer drugs and three for other diseases and conditions. As a result, the growing focus on personalized medicine is propelling the growth of the small molecule targeted therapy market.
Major companies operating in the small molecule targeted therapy market are focusing on developing innovative approaches such as oral small molecules to enhance targeted delivery, improve patient adherence, and address specific molecular pathways in oncology and other chronic conditions. Oral small molecule refers to a low-molecular-weight drug administered orally, designed to enter cells efficiently and specifically target disease-associated proteins or pathways. For example, in June 2025, Kura Oncology Inc., a US-based biotechnology company, received FDA approval for a New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory acute myeloid leukemia (AML) with nucleophosmin 1 (NPM1) mutations. This oral targeted therapy is intended for adult patients with relapsed or refractory AML carrying NPM1 mutations, addressing a significant unmet medical need. It demonstrates a favorable safety profile and has shown promising efficacy, including notable complete remission rates in clinical trials. By selectively inhibiting the menin-KMT2A interaction, ziftomenib disrupts leukemic cell proliferation and provides new treatment options for this difficult-to-treat AML subtype.
In May 2025, Eli Lilly and Company, a US-based pharmaceutical firm, acquired SiteOne Therapeutics Inc. for an undisclosed sum. Through this acquisition, Eli Lilly and Company aims to enhance its pain treatment portfolio by creating innovative, non-addictive therapies for chronic pain using advanced sodium channel inhibitors. SiteOne Therapeutics Inc. is a US-based pharmaceutical firm that provides small molecule targeted therapies.
Major companies operating in the small molecule targeted therapy market are F. Hoffmann-La Roche AG (Roche), Merck KGaA, Pfizer Inc., Bayer AG, Sanofi S.A., Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, Blueprint Medicines Corporation, Kura Oncology Inc., G1 Therapeutics Inc., Ascentage Pharma Group International Inc., Rgenta Therapeutics Inc., Verastem Inc.
North America was the largest region in the small molecule targeted therapy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the small molecule targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The small molecule targeted therapy market consists of sales of tyrosine kinase inhibitors, proteasome inhibitors, and BCL-2 inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Small Molecule Targeted Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses small molecule targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for small molecule targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small molecule targeted therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type Of Therapy: Chemotherapy; Targeted Therapy; Immunotherapy
2) By Drug Class: Monoclonal Antibodies; Small Molecule Inhibitors; Combination Therapies
3) By Mechanism Of Action: Kinase Inhibitors; Proteasome Inhibitors; Aromatic Hydrocarbon Receptor (Ahr) Modulators; Cell Cycle Inhibitors
4) By Disease Indication: Cancer; Autoimmune Diseases; Infectious Diseases
5) By Route Of Administration: Oral; Intravenous; Subcutaneous
Subsegments:
1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anti-microtubule Agents
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Fintech, Blockchain, Regtech & Digital Finance
4.2. Major Trends
4.2.1 Increasing Expansion Of Target-Specific Drug Development
4.2.2 Rising Use Of Pathway-Modulating Therapies
4.2.3 Growing Adoption Of Oral Small Molecule Treatments
4.2.4 Enhanced Focus On Disease-Specific Molecular Targets
4.2.5 Expansion Of Combination Small Molecule Regimens
5. Small Molecule Targeted Therapy Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Research Institutes
5.4 Pharmaceutical Companies
5.5 Contract Research Organizations
6. Small Molecule Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Small Molecule Targeted Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Small Molecule Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Small Molecule Targeted Therapy Market Size, Comparisons And Growth Rate Analysis
7.3. Global Small Molecule Targeted Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Small Molecule Targeted Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Small Molecule Targeted Therapy Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Small Molecule Targeted Therapy Market Segmentation
9.1. Global Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Chemotherapy, Targeted Therapy, Immunotherapy
9.2. Global Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Monoclonal Antibodies, Small Molecule Inhibitors, Combination Therapies
9.3. Global Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.4. Global Small Molecule Targeted Therapy Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cancer, Autoimmune Diseases, Infectious Diseases
9.5. Global Small Molecule Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Intravenous, Subcutaneous
9.6. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies
10. Small Molecule Targeted Therapy Market Regional And Country Analysis
10.1. Global Small Molecule Targeted Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Small Molecule Targeted Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Small Molecule Targeted Therapy Market
11.1. Asia-Pacific Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Small Molecule Targeted Therapy Market
12.1. China Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Small Molecule Targeted Therapy Market
13.1. India Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Small Molecule Targeted Therapy Market
14.1. Japan Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Small Molecule Targeted Therapy Market
15.1. Australia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Small Molecule Targeted Therapy Market
16.1. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Small Molecule Targeted Therapy Market
17.1. South Korea Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Small Molecule Targeted Therapy Market
18.1. Taiwan Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Small Molecule Targeted Therapy Market
19.1. South East Asia Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Small Molecule Targeted Therapy Market
20.1. Western Europe Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Small Molecule Targeted Therapy Market
21.1. UK Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Small Molecule Targeted Therapy Market
22.1. Germany Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Small Molecule Targeted Therapy Market
23.1. France Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Small Molecule Targeted Therapy Market
24.1. Italy Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Small Molecule Targeted Therapy Market
25.1. Spain Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Small Molecule Targeted Therapy Market
26.1. Eastern Europe Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Small Molecule Targeted Therapy Market
27.1. Russia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Small Molecule Targeted Therapy Market
28.1. North America Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Small Molecule Targeted Therapy Market
29.1. USA Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Small Molecule Targeted Therapy Market
30.1. Canada Small Molecule Targeted Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Small Molecule Targeted Therapy Market
31.1. South America Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Small Molecule Targeted Therapy Market
32.1. Brazil Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Small Molecule Targeted Therapy Market
33.1. Middle East Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Small Molecule Targeted Therapy Market
34.1. Africa Small Molecule Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Segmentation By Drug Class, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Small Molecule Targeted Therapy Market Regulatory and Investment Landscape
36. Small Molecule Targeted Therapy Market Competitive Landscape And Company Profiles
36.1. Small Molecule Targeted Therapy Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Small Molecule Targeted Therapy Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Small Molecule Targeted Therapy Market Company Profiles
36.3.1. F. Hoffmann-La Roche AG (Roche) Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
37. Small Molecule Targeted Therapy Market Other Major And Innovative Companies
Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, Blueprint Medicines Corporation, Kura Oncology Inc, G1 Therapeutics Inc, Ascentage Pharma Group International Inc, Rgenta Therapeutics Inc, Verastem Inc
38. Global Small Molecule Targeted Therapy Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Small Molecule Targeted Therapy Market
40. Small Molecule Targeted Therapy Market High Potential Countries, Segments and Strategies
40.1 Small Molecule Targeted Therapy Market In 2030 - Countries Offering Most New Opportunities
40.2 Small Molecule Targeted Therapy Market In 2030 - Segments Offering Most New Opportunities
40.3 Small Molecule Targeted Therapy Market In 2030 - Growth Strategies
